DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension

Information source: Bayer
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hypertension

Intervention: Pritor (Telmisartan , BAY68-9291) (Drug)

Phase: N/A

Status: Completed

Sponsored by: Bayer

Official(s) and/or principal investigator(s):
Bayer Study Director, Study Director, Affiliation: Bayer


The main purpose of this study is to asses the efficacy and safety of telmisartan, with the special attention on the influence of telmisartan on selected metabolic parameters of patients.

Clinical Details

Official title: A Non-Interventional, Post-Marketing Surveillance Phase IV Study to Asses the Efficacy and Safety of Telmisartan, With the Special Attention on the Influence of Telmisartan on Selected Metabolic Parameters of Patients

Study design: Observational Model: Cohort, Time Perspective: Prospective

Primary outcome: Efficacy and safety of the treatment with telmisartan reported by the physician

Secondary outcome: Changes in metabolic parameters in telmisartan treated patients


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Age over 18

- Untreated or ineffectively treated arterial hypertension

Exclusion Criteria:

- Cholestatic disorders and severe hepatic failure

- Allergy to telmisartan

- Pregnancy and lactation period

Locations and Contacts

Many Locations, Croatia

Many Locations, Poland

Many Locations, Slovakia

Many Locations, Slovenia

Additional Information

Click here and search for drug information provided by the FDA

Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product

Starting date: September 2006
Last updated: January 19, 2010

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017